Novo's Clayton facility makes semaglutide, the active ingredient in Wegovy and diabetes drug Ozempic. It also does ...

A federal appeals court on Monday rejected Novo Nordisk's challenge to the U.S. government’s program that gives its Medicare ...

Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and Wegovy are ...

Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

Novo Nordisk (NYSE:NVO) shares have moved little in recent sessions, with investors taking a wait-and-see approach. Market participants are weighing the company's recent performance metrics against ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Yesterday, the U.S. Court of Appeals for the Third Circuit nixed the latest challenge filed by a major pharmaceutical company ...

A federal appeals court unanimously rejected a Novo Nordisk challenge to Medicare’s drug price negotiation program, a ruling ...